Marijuana Stocks & Publicly Traded Cannabis Companies

Cannabis firm MedMen distances itself from stock promoter after OTC scrutiny

Published March 5, 2019

California-based marijuana retailer MedMen disclosed that a content production firm it paid wound up promoting the company’s stock through at least one online article, a move that drew scrutiny from U.S. over-the-counter trading officials. According to a news release, MedMen hired Winning Media in January to help bolster its image through online ads. Then, on […]

Read More

GW Pharma denies supply issues with marijuana-based drug Epidiolex after stock falls

Published February 21, 2019

GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply issues related to the cannabis-derived drug after a tweet from a patient’s father complained he could not source the medicine. GW’s stock was down more than 3% on Wednesday on the Nasdaq after the tweet from San […]

Read More

Canadian marijuana grower Village Farms approved for Nasdaq listing

Published February 15, 2019

Village Farms International, a Canadian greenhouse grower with a 50% stake in British Columbia-based cannabis firm Pure Sunfarms Corp., has graduated to the Nasdaq exchange. The company says it will leave the over-the-counter markets – where it trades as VFFIF – and list on the Nasdaq Capital Market as VFF. A date for the listing […]

Read More

After string of successes, multistate cannabis firm MedMen forced to confront adversity

Published February 14, 2019 | By John Schroyer

In November, California-based cannabis retailer MedMen began advertising for a crisis management planning manager. According to the job posting, the position was intended to support the company’s “employees and business units in building, sustaining and improving MedMen’s capability to prepare for, mitigate against, respond to and recover from all hazards.” In hindsight, the posting seemed […]

Read More

San Francisco cannabis retailer acquired by Canada’s TerrAscend for $118M

Published February 11, 2019

Canadian marijuana firm TerrAscend announced it will acquire California-based The Apothecarium in a deal worth more than $118 million (157 million Canadian dollars). In a news release, the Toronto-based company said the deal’s terms included $73.7 million in cash plus another $44.7 million worth of stock. In return, TerrAscend will receive: Three retail shops in […]

Read More

Auxly, FSD Pharma end cannabis cultivation venture over contractual disputes

Published February 7, 2019

Auxly Cannabis Group, a vertically integrated marijuana company in Vancouver, British Columbia, said Thursday it is ending a joint venture with cultivator FV Pharma, a wholly owned subsidiary of Cobourg, Ontario-based FSD Pharma. The move, linked to contractual disagreements between the two companies and concerns over infrastructure, follows FSD’s claim a day earlier that it […]

Read More

Former CFO sues cannabis firm MedMen, alleging breach of contract, other misdeeds

Published January 31, 2019 | By John Schroyer

The former chief financial officer of MedMen Enterprises filed suit against the California-based company this week, alleging top executives forced him to “choose between complying with his fiduciary duty to the company and its shareholders or turning a blind eye and a deaf ear to improper and unlawful behavior.” James Parker, who resigned as CFO in November, […]

Read More

Medical marijuana firm Khiron expands in South America with CA$13.7M acquisition

Published January 29, 2019

Khiron Life Sciences Corp., an integrated medical cannabis company with core operations in Colombia, has agreed to buy Uruguay’s NettaGrowth International in a deal valued at 13.7 million Canadian dollars ($10.3 million). NettaGrowth is in the process of completing its acquisition of Dormul, which secured a cannabis cultivation license in Uruguay with capacity up to 120 […]

Read More

Chart: US-affiliated medical cannabis firms led fundraising on Canadian Securities Exchange in 2018

Published January 28, 2019 | By Maggie Cowee

U.S.-affiliated medical cannabis companies dominated Canadian Securities Exchange (CSE) fundraising in 2018, raising nearly $2 billion through 50 equity-related deals. As of December 2018, 47% of the 124 cannabis-related companies trading on the CSE were based in the United States or had U.S. assets or interests. Cannabis-related companies in the life sciences sector – which […]

Read More